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Abstract
Background and Aim: Chronic hepatic damage leads to liver fibrosis, which is characterized by the accumulation of
collagen-rich extracellular matrix. However, the mechanism by which E3 ubiquitin ligase is involved in collagen synthesis in
liver fibrosis is incompletely understood. This study aimed to explore the involvement of the E3 ubiquitin ligase synoviolin
(Syno) in liver fibrosis.
Methods: The expression and localization of synoviolin in the liver were analyzed in CCl4-induced hepatic injury models and
human cirrhosis tissues. The degree of liver fibrosis and the number of activated hepatic stellate cells (HSCs) was compared
between wild type (wt) and Syno
+/2 mice in the chronic hepatic injury model. We compared the ratio of apoptosis in
activated HSCs between wt and Syno
+/2 mice. We also analyzed the effect of synoviolin on collagen synthesis in the cell line
from HSCs (LX-2) using siRNA-synoviolin and a mutant synoviolin in which E3 ligase activity was abolished. Furthermore, we
compared collagen synthesis between wt and Syno
2/2 mice embryonic fibroblasts (MEF) using quantitative RT-PCR,
western blotting, and collagen assay; then, we immunohistochemically analyzed the localization of collagen in Syno
2/2 MEF
cells.
Results: In the hepatic injury model as well as in cirrhosis, synoviolin was upregulated in the activated HSCs, while Syno
+/2
mice developed significantly less liver fibrosis than in wt mice. The number of activated HSCs was decreased in Syno
+/2
mice, and some of these cells showed apoptosis. Furthermore, collagen expression in LX-2 cells was upregulated by
synoviolin overexpression, while synoviolin knockdown led to reduced collagen expression. Moreover, in Syno
2/2 MEF cells,
the amounts of intracellular and secreted mature collagen were significantly decreased, and procollagen was abnormally
accumulated in the endoplasmic reticulum.
Conclusion: Our findings demonstrate the importance of the E3 ubiquitin ligase synoviolin in liver fibrosis.
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All forms of chronic hepatic damage ultimately result in liver
cirrhosis or fibrosis, which is among the important causes of
morbidity and mortality worldwide. Cirrhosis is essentially late-
stage fibrosis triggered by chronic liver damage from various
causes, including hepatitis virus infection, alcohol abuse, or
nonalcoholic steatohepatitis [1]. Liver fibrosis can progress to
widespread distortion of the normal hepatic architecture as a result
of continuous liver damage and regeneration. Thus, controlling
liver fibrosis is important for preventing the development of liver
cirrhosis. However, currently, there are no approved anti-fibrotic
therapies for liver cirrhosis, underscoring the importance of
clarifying the underlying pathogenetic mechanisms.
The principal resident liver cells that drive liver fibrosis are
hepatic stellate cells (HSCs), i.e., perisinusoidal cells whose
primary role in the normal liver is the uptake and storage of
vitamin A (retinoids) [1,2]. In the adult liver, quiescent HSCs are
located in the space of Disse between hepatocytes and sinusoidal
endothelial cells. They play a pivotal role in liver physiology;
following liver damage, HSCs become ‘‘activated,’’ i.e., they
differentiate into myofibroblasts, proliferate, and produce an
extracellular matrix (ECM) network mainly comprising collagen,
which is the hallmark of a fibrotic scar [3]. Following acute
damage, activated HSCs probably promote hepatocyte prolifera-
tion and organ repair [4,5]; however, following chronic damage,
the excessive ECM produced by these cells disrupts the hepatic
cytoarchitecture, eventually leading to fibrosis and cirrhosis [1].
Therefore, pathways regulating collagen synthesis by activated
HSCs in liver fibrosis represent a critical area for further
investigation.
Collagen I is a major component of the extracellular matrix
essential for supporting and organizing most tissues. The collagen I
molecule is a trimer of two pro-a1(I) chains and one pro-a2(I)
chain; the triple helix formation of the collagen occurs in the
endoplasmic reticulum (ER) [6]. Further, collagen I regulates
several posttranslational modifications [6]. During procollagen
biosynthesis in the ER, several molecular chaperones assist in the
correct folding of collagen [7]. The procollagen molecules that are
fully modified and folded are then transported to the Golgi
apparatus. In the Golgi cisternae, the procollagen molecules are
stacked laterally, form aggregates and are further modified for the
sorting to their final destinations. Finally, the procollagen
aggregates are secreted into the extracellular space, where the
N- and C-propeptides are enzymatically cleaved off, thereby
generating mature collagen molecules [8]. Thus, the collagen
triple helix must be correctly folded to allow its secretion from the
cell. Collagen I chains containing mutations that affect initial
chain association, such as those in the pro-a1(I), are removed by
retrotranslocation of monomeric unfolded mutant collagen chains
into the cytosol, followed by ER-associated degradation (ERAD)—
an ATP-dependent ubiquitin-proteasome process that reduces the
burden of excess unfolded proteins on the ER [9]. These
proteasomal degradation systems are also involved in the collagen
I synthesis of HSCs [10]. However, there is no evidence that in the
ERAD system, the E3 ubiquitin ligase directly ubiquitinates
unfolded collagen I chain [9].
We previously characterized a novel molecule termed synovio-
lin, which is strongly expressed in rheumatoid synovial fibroblasts
and contributes to the pathogenesis of rheumatoid arthritis (RA)
[11–16]. Synoviolin is an E3 ubiquitin ligase, which is a human
homologue of the murine ER-resident RING-H2 ubiquitin ligase
Hrd1p/Der3p [17–20]. The ER plays an important role in protein
folding and processing. When the level of unfolded proteins in the
ER exceeds the folding capacity of this organelle, defective
proteins are eliminated by the ERAD system [9], in which the E3
ubiquitin ligase synoviolin is involved. E3 ubiquitin ligases catalyze
ubiquitination, which can tag specific proteins for degradation
[21]. Synoviolin is ubiquitously distributed among mammals, and
in humans, it is expressed most strongly in the liver among all
tissues [19]. We have demonstrated that synoviolin-deficient
homozygous (Syno
2/2) mice suffer death around embryonic day
13.5 (E13.5) because they have a hematopoietic abnormality
provoked by hepatocellular apoptosis [22].
On the basis of these observations, we hypothesized that
synoviolin may also play important roles in physiological and
various pathological conditions of the liver. Here, we have
explored the involvement of synoviolin in liver fibrosis using a
mouse model and in human liver cirrhosis.
Materials and Methods
Antibodies
The antibodies used in this study were as follows: anti-
synoviolin/Hrd1 monoclonal antibody as described previously
[18], anti- Synoviolin/HRD1 polyclonal antibody (Santa Cruz
Biotechnology, Inc.), anti-alpha smooth muscle actin (a-SMA)
monoclonal antibody (Dako), anti-Flag antibody (anti-Flag M2
monoclonal antibodies; Sigma Chemical Co.), anti-KLF6/Zf9
antibody (R-173; Santa Cruz), anti-mouse collagen type I
polyclonal antibody (AB765P; Millipore), anti-GM130 monoclo-
nal antibody (BD Bioscience, Franklin Lakes, NJ), anti-protein
disulfide isomerase (PDI) monoclonal antibody (Stressgen) and
anti-b-actin antibody (Sigma).
Isolation of MEFs
Mouse embryonic fibroblasts (MEFs) were isolated from E12.5
embryos of wild-type and Syno
2/2 mice as described previously
[22].
Preparation of cellular protein and immunoblot analysis
Proteins were extracted from MEFs and LX-2 cells using a cell
extraction buffer containing 0.05 M Tris-HCl, pH 8.0, 0.15 M
NaCl, 5.0 mM ethylenediaminetetraacetic acid (EDTA), 1% NP-
40, and protease inhibitors (1 mg/ml leupeptin and pepstatin) at
4uC. The protein extracts were resolved by 8–10% SDS-PAGE,
transferred onto a nitrocellulose membrane, and incubated with
primary antibodies followed by horseradish peroxidase-conjugated
secondary antibodies. The antigen-antibody complexes were
visualized using an ECL detection system (Promega).
Measurement of soluble secreted collagen
Cells were seeded in low-glucose Dulbecco’s Modified Eagle
Medium (DMEM) containing 1% fetal bovine serum (FBS) at 24 h
before collagen measurement. The total soluble collagen in the
culture supernatants was measured by the Sircol collagen assay
method (Biocolor) according to the manufacturer’s instructions.
We measured the amount of soluble collagen by subtracting the
amount of soluble collagen within 1% FBS medium from the
amount of total soluble collagen, and expressed it as the ‘‘relative
secreted protein’’ by dividing the amount of soluble collagen by
the amount of total protein in each sample. The assay was
performed in triplicate, and the mean values of each sample were
calculated.
Cell culture and transient transfection
The LX-2 cell line was established and characterized as
described previously [23].
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was supplemented with 1% penicillin, 1% streptomycin, and 10%
FBS. The cells were seeded in low-glucose DMEM containing
0.5% FBS at 24 h before the transient transfection experiments.
Transient transfections of the LX-2 cell line were performed using
FuGENE 6 (Roche) according to the manufacturer’s instructions.
LX-2 cells (2610
5) were seeded into each well of a 6-well plate or
1610
6 cells were seeded into 100-mm dishes and grown overnight.
RNA interference assay
siRNA with 21 nucleotides was chemically synthesized at
Hokkaido System Science (Hokkaido, Japan). The sequences of
the synoviolin siRNA oligoribonucleotides were as previously
described [24]. Next, 50 nmol of annealed RNA duplex was
transfected using Lipofectamine 2000 according to the manufac-
turer’s recommendations. Firefly-scrambled synoviolin siRNA was
used as the negative control as described previously [24].
Primers
The primers used to amplify the coding sequences in the PCR
were as follows (sense and antisense): mouse klf6: 59-CCTGGAG-
GAATATTGGCAAC-39 and 59-AGGTCTTCCTGGCTGT-
CAAA-39; human synoviolin: 59-TTCGTCAGCCACGCCTAT-
39 and 59-GAGCACCATCGTCATCAGG-39; mouse synoviolin:
59-TACCTCACTGTGCTGGCTTC-39 and 59-AAGGGGCA-
GCAGATACCAC-39; mouse Acta2: 59-GACACCACCCACC-
CAGAGT-39 and 59-ACATAGCTGGAGCAGCGTCT-39; hu-
man COL1A1: 59-CCCCTGGAAAGAATGGAGAT-39 and 59-
AATCCTCGAGCACCCTGA-39; mouse Col1al: 59-CCCC-
TGGAAAGAATGGAGAT-39 and 59-AATCCTCGAGCACC-
CTGA-39; human b-ACTIN: 59-CCAACCGCGAGAAGATGA-
39 and 59-TCCATCACGATGCCAGTG-39; mouse b-actin: 59-
AAGGCCAACCGTGAAAAGAT-39 and 59-GTGGTACGAC-
CAGAGGCATAC-39; and 18S rRNA: 59-GCTGCTTTAA-
GACCTACCGATG-39 and 59-GGATCAAGTTCACAGGC-
AACTA-39.
Real-time PCR
Total RNA from MEFs or LX-2 cells was isolated using Isogen
(Nippon Gene, Tokyo, Japan), and cDNA was synthesized. Real-
time PCR relative quantification analysis was performed using the
FastStart Universal Probe Master (Rox; Roche Applied Science,
Indianapolis, IN) and probes from the universal probe library set
(Roche) with the ABI Prism 7500 Sequence Detection System and
software, according to the manufacturer’s recommendations
(Applied Biosystems). The mRNA level was normalized relative
to the amount of the transcript of b-actin, a housekeeping gene, or
18S rRNA.
Plasmid construction
The constructions of pcDNA3/synoviolin wt-FLAG or C307S-
FLAG and pcDNA3 plasmids have been described previously
[18,22,24,25]; similarly, the construction of KLF6 wt has also been
described [26].
Mouse models
Synoviolin-deficient mice were generated as described previ-
ously [18]. Wt C57/BL6 mice were obtained from the Jackson
Laboratory. These mice were 6–7 weeks of age. To generate an
acute hepatic injury model, wt mice were administered a single
dose of 2.0 mL/kg 50% CCl4 in olive oil. They were then
sacrificed 3–72 h after the injection, and their livers were used for
further analysis as previously described [27].
To generate a liver fibrosis model, wt and Syno
+/2 mice were
injected with 0.5% phenobarbital water for pretreatment and then
10.0 mL/kg 2.5% w/v CCl4 or pure olive oil, twice a week at
equal intervals for 3 weeks. All the treated mice were sacrificed 3
weeks after the first administration of CCl4. We sacrificed these
chronic hepatic injury model mice 48 h after the final CCl4
exposure. Liver tissue sections were stained with Masson’s
trichrome stain. For the semiquantitative analysis of fibrosis, the
blue-stained area in Masson’s trichrome-stained sections was
measured using the NIH Image software. Three fields were
randomly selected from each of the 3 sections.
Immunohistochemistry
Tissue blocks were cut (approximately 10 mm 610 mm
610 mm) and immediately fixed in 10% neutral buffered formalin
for 48 h. After fixation, the tissues were immersed in 70% ethanol
until processing. All tissues were processed simultaneously. The
fixed tissues were dehydrated in ethanol, cleared in xylene, and
embedded in paraffin blocks, which were cooled before sectioning.
The mouse livers were sectioned into 4-mm-thick slices, and the
sections were mounted on silane-coated slides. For antigen
retrieval, the slides were heated in a microwave oven and then
allowed to cool. Endogenous peroxidase was blocked with 3%
H2O2 for 15 min at room temperature. Immunohistostaining was
performed using antibodies against synoviolin (10 mg/mL) (Santa
Cruz). Immunoreactive materials were visualized using a biotiny-
lated anti- rabbit IgG antibody (Dako), peroxidase-labeled
streptavidin, and diaminobenzidine. Pathologically confirmed
human liver tissue arrays were obtained from U.S. Biomax
(Rockville, MD).
Double immunofluorescence staining for liver tissues
and culture cells
Incubations with primary antibodies, i.e., rabbit antibody (anti-
Synoviolin/HRD1 polyclonal antibody or anti-mouse collagen
type I polyclonal antibody) and mouse monoclonal antibody (anti-
a-SMA monoclonal antibody, anti-GM130 monoclonal antibody,
or anti-PDI monoclonal antibody), were conducted at room
temperature for 1 h. After washing, cells were incubated with
biotinylated anti-rabbit immunoglobulin (IgG (1:150; Vector
Laboratories, Burlingame, CA, USA) and Alexa Fluor 594 (red)
anti-mouse IgG (1:150; Invitrogen) at room temperature for 1 h.
After washing, reaction with streptavidin and Alexa Fluor 488
(green) conjugate (1:150; Molecular Probes, Eugene, OR, USA)
was conducted at room temperature for 1 h. After washing,
coverslips were mounted using Vectashield medium with 49,6-
diamidino-2-phenylindole (Roche Diagnostics, Mannheim, Ger-
many). Fluorescent images were visualized using a Zeiss LSM 510
META confocal fluorescence microscope (Carl Zeiss, Jena,
Germany).
TUNEL staining
For detection of cells undergoing apoptosis, tissue sections were
subjected to terminal dUTP nick-end labeling (TUNEL), using an
In Situ Apoptosis Detection kit (MK-500; Takara Shuzo Co.,
Tokyo, Japan), according to the manufacturer’s recommenda-
tions. Paraffin-embedded tissue sections of rat mammary gland
were used as a positive control [28] (Fig. S1). After TUNEL
staining, sections were subsequentlyincubated with monoclonal
anti-human a-SMA antibody and Alexa Fluor 594 (red) anti-
mouse IgG (1:150; Invitrogen) at room temperature for 1 h. The
number of double-positive cells for TUNEL and a-SMA was
counted in the stained sections at 400-fold field magnification
Synoviolin and Liver Fibrosis
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per section.
Statistical analysis
Statistical analysis was performed using a commercially
available software package (Prism 5.0; Graphpad Software). Data
were tested by one-factor ANOVA with Tukey’s post-hoc analysis
or Student’s t-test. Differences were considered statistically
significant at P,0.05. All results were derived from at least 3
independent experiments.
Ethical considerations
All experiments with mice were approved by the ethics
committee for Animal Experiments of St. Marianna University
School of Medicine. All the experimental protocols described in
this study were approved by the Ethics Review Committee of St.
Marianna University School of Medicine (Approval number
01008).
Results
Increased expression of synoviolin in activated HSCs in
hepatic injury
First, we examined whether synoviolin is expressed under
pathophysiological conditions by using an acute hepatic injury
model induced by CCl4 administration. After confirming acute
liver damage by the increased serum levels of alanine aminotrans-
ferase (ALT) (Fig. 1A), we analyzed the time-course of mRNA
expression for synoviolin, Kru ¨ppel-like factor 6 (KLF6)—a key
transcriptional factor contributing to liver fibrosis [29], a-SMA-
activated HSC marker, and the collagen I gene (COL1A1) using
real-time quantitative reverse transcription polymerase chain
reaction (RT-PCR) (Fig. 1B). As has been reported previously,
rapid expression of KLF6 mRNA was observed 3 h after CCl4
administration, which decreased subsequently (Fig. 1B). Maximum
expression of synoviolin mRNA was observed at 24 h, after which
it gradually decreased (Fig. 1B). Increased expression of a-SMA
mRNA was noted at 48 h (Fig. 1B), and the expression of
COL1A1 mRNA increased after 72 h (Fig. 1B). This parallel
expression of synoviolin and a-SMA mRNA (Fig. 1B) in liver
tissues suggests that the expression of synoviolin is potentially
induced along with the processes of HSCs activation in acute
hepatic injury. Therefore, to determine whether the expression of
synoviolin is associated with HSCs activation in hepatic injury, we
initially analyzed the expression of synoviolin by immunohisto-
chemistry in the liver 48 h after CCl4 administration. Synoviolin
was highlyexpressed in hepatic nonparenchymal cells, among
which HSCs are a prominent component (Fig. 1C). To localize the
expression in the HSCs, we analyzed the dual expression of
synoviolin and the activated HSC marker a-SMA in liver sections
by double-labeled fluorescent immunohistochemical analysis
(Fig. 1D). The sites of synoviolin expression were in part co-
localized with a-SMA (Fig. 1D). Furthermore, to determine
whether synoviolin is induced in the activated HSCs of human
cirrhosis patients, we analyzed the co-localization of synoviolin
and a-SMA in healthy and cirrhotic liver sections by double-
labeled fluorescent immunohistochemical analysis using a liver
human tissue array (Fig. 1E). The sites of synoviolin expression
were co-localized with a-SMA in cirrhotic livers but not in healthy
livers (Fig. 1E). These results suggest that synoviolin is overex-
pressed in activated HSCs both in the acute phases of hepatic
injury mice model and in the chronic phase of human hepatic
injury.
Syno
+/2mice are resistant to liver fibrogenesis
Because activated HSCs are considered key players in the
development of liver fibrosis, we investigated whether synoviolin is
essential to the development of liver fibrosis. Therefore, using a
liver fibrosis model induced by chronic administration of CCl4,w e
compared the degree of liver fibrosis between wt (n=14) and
Syno
+/2 mice (n=12). For Syno
+/2 mice, it is known that the
expression level of synoviolin is approximately half as compared to
that in wt mice [18] (Fig. 2). While liver fibrogenesis was apparent
with the formation of bridging fibrosis, i.e., interlobular connective
tissue fibrosis, was significant in the wt mice, fibrosis was
significantly reduced in the Syno
+/2 mice following the chronic
administration of CCl4 (Fig. 2A). Moreover, the percentage of the
fibrotic area as assessed using NIH Image software was
significantly lower in the Syno
+/2 mice than in wt mice (Fig. 2B).
There was no significant difference in the serum levels of ALT,
lactate dehydrogenase (LDH), total bilirubin (T-bil), total protein
(TP), albumin (Alb), and the serum albumin/globulin (A/G) ratio
between the wt and Syno
+/2 mice both in natural conditions and
in this liver fibrosis model (Fig. S2 and S3). These similar serum
levels of ALT elevation suggest that the degree of chronic hepatic
injury is almost identical between wt and Syno
+/2 mice. However,
despite the similar levels of chronic hepatic injury, the degree of
liver fibrogenesis was lower in the Syno
+/2 mice as compared with
than in wt mice (Fig. 2).
Increased number of apoptotic HSCs in liver fibrosis
lesions of Syno
+/2 mice
Based on the induction of synoviolin in activated HSCs (Fig. 1)
and the decreased fibrosis area in Syno
+/2 mice compared to wt
mice (Fig. 2), we hypothesized the two following possibilities: (1)
synoviolin may protect activated HSCs from apoptosis, which then
contributed to fibrogenesis because synoviolin is known to have an
anti-apoptotic effect [12] or (2) synoviolin is directly involved in
collagen production in activated HSCs. Although these possibil-
ities are not mutually exclusive, to investigate whether synoviolin
expression alters the apoptosis of activated HSCs between wild-
type and synoviolin+/2 mice, we initially analyzed the number of
activated HSCs (a-SMA-positive cells) in liver sections between wt
(n=14) and Syno
+/2 mice (n=12) using a liver fibrosis model
induced by the chronic administration of CCl4 (Fig. 3A). The
partial co-localization of synoviolin and a-SMA was also
demonstrated in the chronic phase (Fig. 3A), and the number of
a-SMA-positive cells was decreased in the Syno
+/2 mice as
compared to that in the wt mice (Fig. 3B). Furthermore, we
analyzed the dual expression of TUNEL and a-SMA in liver
sections of the chronic liver fibrosis model using wt and
synoviolin+/2 mice by double-labeled fluorescent immunohisto-
chemical analysis, and compared the number of TUNEL and a-
SMA double-positive cells between wt (n=14) and Syno
+/2 mice
(n=12). As shown in Fig. 3C and 3D, the number of apoptotic
HSCs was increased in Syno
+/2 mice, suggesting that Syno
+/2
mice are resistant to liver fibrosis following the enhanced apoptosis
of HSCs.
Synoviolin regulates secreted collagen expression in
activated HSCs
To test the hypothesis that synoviolin is directly involved in
collagen production in activated HSCs, we analyzed the effect of
synoviolin on secreted collagen production using the LX-2 cell line
(a human activated HSC cell line) [23]. Because of a major
technical limitation in studying primary cultured stellate cells that
consistently have very low transfection efficiency—typically less
Synoviolin and Liver Fibrosis
PLoS ONE | www.plosone.org 4 October 2010 | Volume 5 | Issue 10 | e13590Figure 1. In vivo assessment of synoviolin expression in hepatic injury. (A) The serum levels of alanine aminotransferase (ALT) were analyzed
at 0, 3, 24, 48, and 72 h after CCl4 administration in the acute hepatic injury model mice. Data are represented as mean 6 SEM (n=4–5 mice per
group). Unpaired Student’s t-test was used for statistical analysis. *** P,0.001, ** P,0.01. (B) Time-course expression of KLF6, synoviolin, Acta2 (a-
SMA), and COL1A1 (collagen I) mRNA in livers inoculated with CCl4 (black bar) or vehicle (white bar) quantified using real-time RT-PCR. Data are
represented as mean 6 SEM (n=4–5 mice per group). The mRNA level was normalized relative to the amount of the transcript of 18S rRNA, a
housekeeping gene. Unpaired Student’s t-test was used for statistical analysis. *** P,0.001, ** P,0.01, * P,0.05. (C) Immunohistochemical analysis of
liver sections of wt mice at 48 h after treatment with CCl4 (n=4) or vehicle (n=5). The expression and localization of synoviolin (arrows, right panel)
were analyzed using anti-synoviolin antibodies. Normal IgG antibody was used for the negative control (left panels). Scale bar =100 mm. (D) Double-
labeled fluorescent immunohistochemical analysis of liver sections of wt mice at 48 h after treatment with CCl4 (n=4). The nuclei were
counterstained with DAPI (Vectashield). The expression and localization of synoviolin (green) and a-SMA (red)—a marker of activated HSCs, were
analyzed using anti-synoviolin and a-SMA antibodies. Scale bar =200 mm. (E) Double-labeled fluorescent immunohistochemical analysis of liver
sections of human healthy liver (n=30) and cirrhotic liver (n=40) using human tissue array sections. The expression and localization of synoviolin
(green label) a-SMA (red label) were analyzed using anti-synoviolin and a-SMA antibodies. Scale bar =100 mm.
doi:10.1371/journal.pone.0013590.g001
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transfection efficiency of .30% using a commercial reagent [23].
To confirm the involvement of synoviolin in collagen production,
we initially analyzed the effect of synoviolin siRNA on the amount
of secreted collagen using a collagen assay (Fig. 4A). The amount
of soluble secreted collagen in the supernatant of synoviolin
siRNA-transfected LX-2 cells was ,30% less than that produced
by scrambled siRNA-transfected cells (Fig. 4B).
To observe the functional differences between wt and C307S
under conditions of high collagen production, we initially
transfected the LX-2 cells with KLF6 cDNA—which is known
to induce the expression of type I collagen at the transcriptional
level. Then, we transfected the LX-2 cells with empty vector
(mock), wt synoviolin (wt), or mutant synoviolin (C307S) lacking its
E3 ligase activity, and measured the amount of soluble secreted
collagen in the supernatant obtained from the LX-2 cells (Fig. 4C).
Wt synoviolin induced a 1.5-fold increase in the amount of
secreted collagen, while the mutant synoviolin C307S could not
induce any increase in the amount of secreted collagen (Fig. 4D).
These results suggest that the enzymatic activity of synoviolin may
play a partial role in the regulation of collagen synthesis from
activated HSCs.
Reduced maturation of collagen I proteins in embryonic
fibroblasts from Syno
2/2 mice
To investigate the underlying mechanisms, we further analyzed
the effect of synoviolin in the process of collagen synthesis using
primary Syno
2/2MEFs (E12.5; Fig. 5). The amount of soluble
secreted collagen protein in the supernatants of cultured Syno
2/2
MEFs was significantly lower than in that of wt MEFs (Fig. 5A),
while the mRNA expression levels of the type I collagen gene
(COL1A1), that is 80% of all types of collagen in HSCs [30], were
equivalent between Syno
2/2 and wt MEFs (Fig. 5B). We further
analyzed the amounts of soluble collagen I protein in the whole
cell lysates of Syno
2/2 MEFs using anti-collagen I antibody
(Fig. 5C). Interestingly, the amount of cleaved mature collagen I
(70 kDa) was significantly decreased, while the amounts of
procollagen I (148 kDa) were slightly decreased (Fig. 5C and D).
These results suggest that synoviolin is involved in the maturation
of collagen I. Since it is known that the procollagen molecules are
modified and folded in the ER where synoviolin is located [17]
(Fig. S4) and then the mature collagen is transported to the Golgi
apparatus [8], we next analyzed the intracellular localization of
collagen I in wt and Syno
2/2 by immunofluorescence staining
(Fig. 5E). In wt MEFs, a major portion of the intracellular collagen
I was co-localized with GM130, a marker of cis-Golgi compart-
ment, while a minor portion was co-localized with PDI—a marker
of ER—consistent with previous observations [7,31–33] (Fig. 5E).
In contrast, in Syno
2/2 MEFs, the majority of collagen I was co-
localized with PDI, suggesting that the lack of synoviolin caused
accumulation of collagen I in the ER. Notably, in Syno
2/2 MEFs,
this abnormal transport was not observed for laminin, which is the
one of the proteins secreted via the ER-Golgi apparatus pathway,
similar to collagen I (Fig. S5).
Discussion
In this study, we have demonstrated that the E3 ubiquitin ligase
synoviolin is involved in the maturation of collagen I and that
reduced synoviolin expression helps attenuate liver fibrogenesis.
The unfolded protein response (UPR), which is a biological
defense mechanism of cells, involves translation blocking,
chaperone induction, the ERAD system, and the autophagy
system [9,34–36]. An insufficient UPR results in the accumulation
of unfolded proteins in the ER, which may induce ER stress-
mediated apoptosis. ERAD is an ATP-dependent ubiquitin-
proteasome process that functions to reduce the burden of excess
unfolded proteins in the ER [9]. Thus, ERAD is important for the
maintenance of homeostasis in living organisms. Several E3
ubiquitin ligases have already been identified, and their vital
functions have been intensively studied in recent years. Current
research indicates the association of the loss of function of E3
ubiquitin ligases with ERAD and associated disorders. For
example, a loss-of-function mutation of the parkin gene, which
encodes a well-known E3 ubiquitin ligase, results in neuronal
death in the substantia nigra of patients with autosomal recessive
juvenile Parkinsonism [37]. On the other hand, we have
Figure 2. Decreased liver fibrogenesis in Syno
+/2 mice. (A) Liver
fibrosis in wt and Syno
+/2 mice. Wild-type mice (wt: n=14) and Syno
+/2
mice (Syno
+/2; n=12) were injected with CCl4 twice a week for 3 weeks.
Then, liver fibrosis was evaluated by Masson’s trichrome staining. Wild-
type mice (wt: n=2) and Syno
+/2 mice (Syno
+/2; n=2) that were
treated with vehicle were used as negative controls (upper panels).
Scale bar =200 mm. (B) Scatter diagram analysis of fibrosis areas in liver
sections semiquantified using NIH Image software. Data are represent-
ed as mean 6 SEM (wt: n=14, Syno
+/2: n=12 of the CCl4-induced
chronic hepatic injury model). Unpaired Student’s t-test was used for
statistical analysis. * P,0.001.
doi:10.1371/journal.pone.0013590.g002
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E3 ubiquitin ligases with ERAD and the associated disorders; the
overexpression of synoviolin, an E3 ubiquitin ligase that functions
in the ERAD system, is a pathogenic factor in arthropathy [18].
Synoviolin is also strongly expressed in rheumatoid synovial cells
and is involved in the pathogenesis of rheumatoid arthritis (RA)
[11–14]. These data suggest that synoviolin overexpression leads
to ERAD hyperactivation in rheumatoid synovial cells, implicating
the hyperfunctioning of the ERAD system as an important
pathogenic mechanism in diseases, which is a novel concept [14].
In this study, we noted that synoviolin overexpression led to excess
secretion of mature collagen from activated HSCs, while reduced
synoviolin expression resulted in resistance to liver fibrogenesis.
This initial report suggests that hyperactivity of the ERAD system
due to the overexpression of an E3 ubiquitin ligase may cause liver
fibrosis. Our results also support the idea of the hyperfunctioning
of the ERAD system as an important pathogenic mechanism in
liver diseases. Further, our results also suggest that modifications in
ERAD activity may control the fibrogenic potential of HSCs
following liver injury.
In our previous study, we reported that mouse embryonic
fibroblasts from Syno
2/2 are selectively susceptible to ER stress-
induced apoptosis. The MEFs derived from the Syno
2/2 embryos
exhibited high and selective susceptibility to ER stress in vitro along
with increased expressions of ER stress-inducible proteins,
including Bip/Grp78 and CHOP/Gadd153 [22]. These data
Figure 3. Increase in the number of apoptotic activated hepatic stellate cells in Syno
+/2 mice. (A) Double-labeled fluorescent
immunohistochemical analysis of liver sections of wt (n=14) and Syno
+/2 mice (n=12) after treatment with CCl4 twice a week for 3 weeks. The nuclei
were counterstained with DAPI (Vectashield). The expression and localization of synoviolin (green) and a-SMA (red) were analyzed using anti-
synoviolin and a-SMA antibodies. Scale bar =100 mm. (B) The analysis of the number of a-SMA-positive cells in liver sections of wt and Syno
+/2 mice
after treatment with CCl4 twice a week for 3 weeks. Data are represented as mean 6 SEM (wt: n=14, Syno
+/2: n=12 of the CCl4-induced chronic
hepatic injury model). Unpaired Student’s t-test was used for statistical analysis. * P,0.01. (C) Double-labeled fluorescent immunohistochemical
analysis of liver sections of wt and Syno
+/2 mice after treatment with CCl4 twice a week for 3 weeks. The nuclei were counterstained with DAPI
(Vectashield). The expression and localization of TUNEL (green) and a-SMA (red) were analyzed using an in situ apoptosis assay kit and a-SMA
antibodies. Scale bar =100 mm. (D) The analysis of the number of TUNEL and a-SMA double-positive cells in liver sections of wt and Syno
+/2 mice
after treatment with CCl4 twice a week for 3 weeks. Data are represented as mean 6 SEM (wt: n=14, Syno
+/2: n=12 of the CCl4-induced chronic
hepatic injury model). Unpaired Student’s t-test was used for statistical analysis. * P,0.01.
doi:10.1371/journal.pone.0013590.g003
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2/2 MEFs. In this study, the
number of apoptotic activated HSCs was increased in Syno
+/2
mice as compared to those in wt mice in liver fibrosis models using
CCl4, which is a well-known ER stress inducer (Fig. 3D). Under
such severe ER stress conditions, ER stress may lead to
programmed cell death in HSCs; subsequently, the accumulation
of extracellular matrix would be attenuated.
Collagen is essential for tissue repair and regeneration in liver
injury. However, when liver damage persists because of chronic
injury, collagen is produced and secreted in excess by activated
HSCs [38]. Further, among various collagen proteins, collagen I
comprises approximately 90% of the body’s total collagen [39].
However, it is not well understood how collagen is translated,
modified after translation, processed, correctly folded, and
secreted as collagen triple helix. In HSP47-deficient cells, collagen
triple helix formation and stability are impaired, and the
improperly folded triple helices form insoluble aggregates in the
ER [7]. In addition, the role of ERAD in the degradation of
mutant unfolded procollagen I caused by a mutation in the
collagen I gene has also been recently discovered [34–36,40].
Further, the polyubiquitination of procollagen I (148 kDa) was
detected in Mov-IAFS cell lines, and the mutation was found to be
located in the C-propeptide region of the procollagen I chain using
an in vivo ubiquitination assay [35]. These reports suggest that the
posttranslational regulation of collagen expression is crucial in
collagen synthesis. In this study, we found that the amount of
cleaved mature collagen I (70 kDa) was significantly decreased,
while the amount of procollagen I (148 kDa) was not increased by
the lack of synoviolin (Fig. 5D). Furthermore, lack of synoviolin
also caused an accumulation of collagen I in the ER (Fig. 5E).
These data suggest that synoviolin can be involved in the
maturation process of procollagen I synthesis between the ER
and cis-Golgi compartment. ER-resident E3 ubiquitin ligases,
including synoviolin, are crucial in the ERAD system because E3
ubiquitin ligase directly binds to specific target substrates and adds
a polyubiquitin chain. Therefore, we hypothesize that synoviolin
may regulate the quality of collagen protein through the
polyubiquitination of the unfolded procollagen directly or may
regulate the quality of these collagen-specific molecular chaper-
ones indirectly via its ubiquitination and degradation pathways.
We are currently investigating the collagen-specific target
substrates of synoviolin.
In conclusion, we have demonstrated that the E3 ubiquitin
ligase synoviolin is essential to the maturation of collagen I. Using
experiments involving a liver fibrosis model with Syno
+/2 mice,
we have also demonstrated that synoviolin is involved in liver
Figure 4. Regulation of secreted collagen expression in culture cells by synoviolin ligase. (A) Immunoblotting analysis of whole-cell
lysates of scrambled siRNA- and synoviolin siRNA-treated LX-2 cells by using anti-synoviolin antibody. The results were derived from 3 independent
experiments. (B) The amount of soluble secreted collagen in culture supernatants of scrambled siRNA- and synoviolin siRNA-treated LX-2 cells as
quantified by the sircol collagen assay method. The amount of collagen was expressed as a ratio by normalization to the protein concentration in
each sample. Data are represented as mean 6 SD (n=3 per group). Unpaired Student’s t-test was used to evaluate statistical significance. * P,0.01.
(C) Immunoblotting analysis of whole-cell lysates of transiently transfected LX-2 cells by using anti-KLF6, HA, and b-actin antibodies. The results were
derived from 3 independent experiments. (D) Effect of synoviolin on the amount of secreted soluble collagen. The control vector (mock), wt
synoviolin-HA, or C307S-HA was co-transfected with the KLF6 vector (KLF6) in LX-2 cells. The amount of secreted soluble collagen in the supernatants
of cultured LX-2 cells was quantified by the sircol collagen assay method. The amount of collagen was expressed as a ratio by normalization to the
protein concentration in each sample. Data are represented as mean 6 SD (n=3 per group). Unpaired Student’s t-test was used to evaluate statistical
significance. * P,0.01, ** P,0.001.
doi:10.1371/journal.pone.0013590.g004
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HSCs. These data emphasize the novel role of the E3 ubiquitin
ligase synoviolin in liver fibrosis.
Supporting Information
Figure S1 Double-labeled fluorescent immunohistochemical
analysis of rat mammary tissue sections as positive and negative
controls for TUNEL staining. The expression and localization of
TUNEL (green) and a-SMA (red) were analyzed using an in situ
apoptosis assay kit and a-SMA antibodies in positive (right panels)
and negative controls (left panels) using rat mammary tissue
sections. The nuclei were counterstained with DAPI (Vectashield).
Scale bar =200 mm.
Found at: doi:10.1371/journal.pone.0013590.s001 (2.23 MB TIF)
Figure S2 HE staining of liver tissue and serum biochemical
tests for wt and Syno+/2 mice in natural conditions. (A) HE
Figure 5. Involvement of synoviolin in collagen synthesis in the maturation of collagen I. (A) Amount of soluble secreted collagen in
culture supernatants of wt and Syno
2/2 MEFs as quantified by the sircol collagen assay method. The amount of collagen was expressed as a ratio by
normalization to the protein concentration in each sample. Data are represented as mean 6 SD (n=3 per group). Unpaired Student’s t-test was used
to evaluate statistical significance. * P,0.01. Immunoblotting analysis of whole-cell lysates of wt and Syno
2/2 MEFs by using anti-synoviolin antibody.
(B) Effect of synoviolin on COL1A1 mRNA expression in wt and Syno
2/2 MEFs. The expression level of COL1A1 mRNA was quantified by real-time RT-
PCR. The mRNA level was normalized relative to the amount of the transcript of b-actin, a housekeeping gene. Data are represented as mean 6 SD
(n=4 per group). Unpaired Student’s t-test was used for statistical analysis. n.s. = not significant. (C) Effect of synoviolin on the expression of
intracellular collagen I. The amount of intracellular collagen I in wt and Syno
2/2 MEFs was analyzed by immunoblot analysis using anti-collagen I,
synoviolin, and b-actin antibodies. The results were derived from 5 independent experiments. (D) The amount of procollagen I and mature collagen I
in wt and Syno
2/2 MEFs semiquantified by NIH Image software. Data are represented as mean 6 SEM (n=5 per group). Unpaired Student’s t-test was
used for statistical analysis. * P,0.05, ** P,0.001. (E) Double immunofluorescence staining was performed using antibodies against type I collagen
(AB765P) and GM130 (a marker of cis-Golgi compartment) or protein disulfide isomerase (PDI; a marker of ER). The results were derived from 3
independent experiments. Scale bar =20 mm.
doi:10.1371/journal.pone.0013590.g005
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PLoS ONE | www.plosone.org 9 October 2010 | Volume 5 | Issue 10 | e13590staining of mouse liver sections from wt and Syno+/2 mice in
natural conditions. Scale bar =200 mm. (B) The serum levels of
aspartate aminotransferase (AST), alanine aminotransferase
(ALT), lactate dehydrogenase (LDH), total bilirubin (T-bil), total
protein, albumin (Alb), and the serum albumin/globulin (A/G)
ratio for wt (n=6) and Syno+/2 mice (n=7) in the natural
condition. Data are represented as mean 6 SEM. Serum
biochemical tests were performed using an outsourced examina-
tion (Mitsubishi Chemical Medience Corporation, Tokyo, Japan).
We measured aspartate aminotransferase (AST), alanine amino-
transferase (ALT), lactate dehydrogenase (LDH), the total
bilirubin (T-bil), total protein (TP), albumin (Alb), and the
albumin/globulin (A/G) ratio using mice serum. The liver sections
were deparaffinized, stained with hematoxylin and eosin (H&E),
and evaluated using light microscopy. We performed the serum
biochemical tests within 48 h after completion of the chronic CCl4
protocol.
Found at: doi:10.1371/journal.pone.0013590.s002 (1.44 MB TIF)
Figure S3 Serum biochemical tests for wt and Syno+/2 mice in
the CCl4-induced chronic hepatic injury model. The serum levels
of aspartate aminotransferase (AST), alanine aminotransferase
(ALT), lactate dehydrogenase (LDH), total bilirubin (T-bil), total
protein, albumin (Alb), and the serum albumin/globulin (A/G)
ratio for wt (n=14) and Syno+/2 mice (n=12) of the CCl4-
induced chronic hepatic injury model. Data are represented as
mean 6 SEM.
Found at: doi:10.1371/journal.pone.0013590.s003 (0.47 MB TIF)
Figure S4 Double immunofluorescence staining was performed
in wt and Syno2/2 MEFs using antibodies against synoviolin and
PDI. Fluorescent images were visualized using a Zeiss LSM 510
META confocal fluorescence microscope (Carl Zeiss, Jena,
Germany). The results were derived from 3 independent
experiments. Scale bar =20 mm.
Found at: doi:10.1371/journal.pone.0013590.s004 (0.78 MB TIF)
Figure S5 The expression and localization of the laminin
protein in wt and Syno2/2 MEFs. (A) Effect of synoviolin on
the expression of laminin. The amount of laminin in whole cell
lysates of wt and Syno2/2 MEFs was analyzed by immunoblot
analysis using anti-laminin, synoviolin, and b-actin antibodies.
The antibodies used in this study were as follows: anti-laminin
polyclonal antibody (Sigma). The results were derived from 3
independent experiments. (B) Double immunofluorescence stain-
ing was performed using antibodies against laminin and GM130
or PDI. Fluorescent images were visualized using a Zeiss LSM 510
META confocal fluorescence microscope (Carl Zeiss, Jena,
Germany). The results were derived from 3 independent
experiments. Scale bar =20 mm.
Found at: doi:10.1371/journal.pone.0013590.s005 (0.96 MB TIF)
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